Skip to main content
Caplight Logo









Kurage

Kurage

Private
LyonHealthcare & Life Scienceshttps://kurage.fr/

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Kurage operates in Healthcare & Life Sciences and is based in Lyon. It was founded in 2020.

Kurage is a medical technology company that develops AI-driven neuroprosthetic devices and functional electrical stimulation systems to restore mobility and autonomy to individuals with neurological injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Kurage Comparables

Compare Kurage with similar companies based on industry and business-model similarity.

Kurage comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CIONIC
90%
Neuro20 Technologies Corp.
82%
Fortis Medical Devices
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Kurage Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Kurage. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Lana Popovic Maneski

CPO & co-founder

Founding Team

Rudi Gombauld

President Kurage Canada, President & Group Chief Executive Officer, Group Chief Strategy Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 136% MoM.

  • Jul 15, 2026

    Grew 16% QoQ, from 32 to 37 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Kurage Filings

Explore SEC and related filing metadata, where available.

Kurage filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Kurage's valuation, stock price, and market status.

Is Kurage a public or private company?

Kurage is a private company.

What is the current stock price of Kurage?

Kurage is a private company, so its shares have no public market price. Caplight tracks Kurage's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Kurage worth (valuation)?

Valuation information for Kurage is not publicly available.

Can I buy Kurage stock?

Kurage shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Kurage's last funding round?

Funding round information for Kurage is not publicly available.

Who are the main investors in Kurage?

Investor information for Kurage is not publicly disclosed.

Will Kurage IPO soon?

No public IPO plans have been announced for Kurage.

How can I track Kurage secondary market activity?

Caplight tracks bids, offers, and trades in Kurage's shares on secondary markets.

Firmographic Details

HeadquartersLyon
Employee Range34
Year Founded2020
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?